글로벌 획득성 메트헤모글로빈혈증 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 획득성 메트헤모글로빈혈증 시장

획득된 메트헤모글로빈혈증 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 4.80%의 CAGR로 성장할 것으로 분석합니다.

후천성 메트헤모글로빈혈증은 급성 메트헤모글로빈혈증이라고도 알려진 희귀 혈액 질환입니다. 다양한 약물, 아닐린 염색제 또는 아질산염이나 질산염과 같은 산화제에 노출되어 혈액 내 메트헤모글로빈 수치가 증가하는 상태입니다. 이 상태의 징후와 증상에는 청색증, 호흡 곤란, 현기증, 피로, 두통, 혼란 및 혼수 상태가 포함됩니다. 증상의 심각성은 메트헤모글로빈의 백분율에 따라 달라집니다.

국소 마취제 사용 증가로 인한 후천성 메트헤모글로빈혈증 유병률 증가와 상처 치료에 질산은 사용 증가가 시장 성장을 견인하는 주요 요인입니다. 또한 질산염이 풍부한 채소의 높은 소비, 의료비 지출 증가, 의료 치료의 발전, 정부와 민간 기관에서 이용 가능한 치료법에 대한 인식을 확산하기 위한 이니셔티브 증가가 후천성 메트헤모글로빈혈증 시장을 확대할 요인입니다.

연구 개발 활동의 증가와 진행 중인 임상 시험은 2021~2028년 예측 기간 동안 후천성 메트헤모글로빈혈증 시장에 유익한 기회를 제공할 것입니다.

그러나 높은 치료 비용과 혈액 제품의 높은 가격이 시장 성장을 방해하는 요인입니다. 농촌 지역에서 훈련된 의사가 부족하고 인지도가 낮으면 위에서 언급한 예측 기간 동안 획득성 메트헤모글로빈혈증 시장에 도전이 될 것입니다.

This acquired methemoglobinemia market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the acquired methemoglobinemia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Acquired Methemoglobinemia Market Scope and Market Size

The acquired methemoglobinemia market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the acquired methemoglobinemia market is segmented into drug therapy, oxygen therapy, blood transfusion therapy and others. Drug therapy has been further sub-segmented into methylene blue, dextrose and ascorbic acid.
• On the basis of diagnosis, the acquired methemoglobinemia market is segmented into blood tests, pulse oximetry, DNA sequencing and others.
• On the basis of dosage, the acquired methemoglobinemia market is segmented into tablet, injection, solution and others.
• On the basis of route of administration, the acquired methemoglobinemia market is segmented into oral, intravenous, intramuscular, topical and others.
• On the basis of symptoms, the acquired methemoglobinemia market is segmented into cyanosis, shortness of breath, dizziness, fatigue, headache and others.
• On the basis of end-users, the acquired methemoglobinemia market is segmented into clinic, hospital and others.

The acquired methemoglobinemia market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Acquired Methemoglobinemia Market Country Level Analysis

Acquired methemoglobinemia market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.

The countries covered in the acquired methemoglobinemia market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the acquired methemoglobinemia market due to the presence of major key players, growing investment for R&D activities, high disposable income, high healthcare expenditure and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Acquired methemoglobinemia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive landscape and global acquired methemoglobinemia market share analysis

Acquired methemoglobinemia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to acquired methemoglobinemia market research.

인수된 메트헤모글로빈혈증 시장 보고서에서 다루는 주요 기업으로는 McGuff Medical Company, Inc., Octapharma AG, GlaxoSmithKline plc, Mylan NV, American Regent, Inc., Teligent, Provepharm Life Solutions, SHREEJI PHARMA INTERNATIONAL., VANSHI CHEMICALS PVT. LTD., Sakshi Dyes and Chemicals, DAIICHI SANKYO COMPANY, LIMITED, Megha International, BELAMI FINE CHEMICALS PVT. LTD., Macsen Laboratories, COSMO PHARMACEUTICALS, A & C, ACP Chemicals Inc., Thermo Fisher Scientific India Pvt. Ltd., Bio-Rad Laboratories, Inc., Caledon Laboratories, Canadawide Scientific, ClearTech, Abundance Naturally, Kedrion, CEDARLANE 등이 있으며, 그 외 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-66725